FDA sends warning letter to Mylan over 'inadequate' manufacturing processes at India plant
Mylan has once again run afoul of the FDA over its lack of upkeep at manufacturing plants.
For the second time in the last 12 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
